Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02856594
PHASE2/PHASE3
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep
Sponsor: Massachusetts General Hospital
View on ClinicalTrials.gov
Summary
This study aims to determine whether, compared with placebo, the nighttime administration of a intravenous dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in extubated post-cardiac surgical patients.
Official title: Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS): A Randomized Placebo-controlled Trial
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
469
Start Date
2017-03-06
Completion Date
2022-02-16
Last Updated
2026-09-01
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Dexmedetomidine
Dexmedetomidine
DRUG
Placebo
Placebo
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States